Smith Julie
Stoke Therapeutics, Inc. · Director
Smith Julie is listed in filings as Director at Stoke Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 5, 2026, including sale activity. Recent filings connect the profile to Stoke Therapeutics, Inc. (STOK) and Exelixis Inc (EXEL). The current snapshot covers public activity from Aug 15, 2024 to Jun 5, 2026. Reported amounts are shown as $524.0K to $887.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $2M44.1k shares | SellFeb 18, 2026 | $44.50 | $55.55 | |
| $887k20k shares | SellFeb 18, 2026 | $44.30 | $55.55 |